ConductScience.org, home

Paper33850002

Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma.

Tang TT and 8 others. Mol Cancer Ther, 2021. Cited by 221 papers, by iCite.

Cite this record

ConductScience Library. Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. Papers, record 33850002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33850002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma.
PubMed
Journal
Mol Cancer Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
221
iCite
Relative citation ratio, by iCite
11.4
iCite
Revised in PubMed
2022-01-25
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tang TTTracy T
2Konradi AWAndrei W
3Feng YYing
4Peng XXiao
5Ma MMingyue
6Li JJian
7Yu FXFa-Xing
8Guan KLKun-Lianghttps://orcid.org/0000-0003-1892-0174
9Post LLeonard

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mesothelioma, MalignantMajor topic
TEA Domain Transcription FactorsMajor topic
Animals
Cell Proliferation
Humans
Lipoylation
Mice
Signal Transduction

Source PubMed

Download CSV of topics

Cited by152

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.

PMIDTitleJournalYearIn PapersSource
42867545Chromosome 6q mediated loss of LATS1 tumour suppression as a targetable mechanism of ultra-high-risk posterior fossa A ependymoma.Acta Neuropathol2026https://conductscience.org/library/papers/42867545PubMed
42806999Experimental assessment of computationally nominated small molecules targeting the YAP-TEAD interface in Hippo pathway-altered mesothelioma cell models.Front Oncol2026https://conductscience.org/library/papers/42806999PubMed
42737441The Crosstalk Between YAP/TAZ and Cancer Metabolism: From Mechanistic Insights to Drug Discovery.Int J Mol Sci2026https://conductscience.org/library/papers/42737441PubMed
42664350LATS1/2 inactivation drives a distinct venous endothelial cell response that contributes to fibrotic remodeling of the lung.Sci Adv2026https://conductscience.org/library/papers/42664350PubMed
42598033TEAD inhibitors re-sensitize drug-resistant NF1 MPNST cells to MEK inhibitors.MicroPubl Biol2026https://conductscience.org/library/papers/42598033PubMed
42524518ZDHHC-Mediated Protein S-Palmitoylation in Cancer: Epigenetic Interfaces, Structural Logic and Therapeutic Targeting.Int J Med Sci2026https://conductscience.org/library/papers/42524518PubMed
42446669TEAD inhibitor induced switch in energy metabolism drives human podocyte injury in vitro.Arch Toxicol2026https://conductscience.org/library/papers/42446669PubMed
42441024YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasis.Cancer Heterog Plast2026https://conductscience.org/library/papers/42441024PubMed
42390936Extracellular matrix reprogramming by the YAP/TAZ/TGF-β2 axis drives immune exclusion in cholangiocarcinoma models.J Clin Invest2026https://conductscience.org/library/papers/42390936PubMed
42365001Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model.Nat Commun2026https://conductscience.org/library/papers/42365001PubMed
42341114Inflammatory monocytes constrain YAP-induced cell proliferation.Sci Adv2026https://conductscience.org/library/papers/42341114PubMed
42338005A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.Int J Cancer2026https://conductscience.org/library/papers/42338005PubMed
42287329The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42287329PubMed
42199411Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42199411PubMed
42128666STK38/L promote tissue growth and cancer by inhibiting the Hippo pathway.Genes Dev2026https://conductscience.org/library/papers/42128666PubMed
42125750TEAD inhibitors synergize with MEK, SHP2 and mTOR inhibitors in NF1 and NF2 cell lines.MicroPubl Biol2026https://conductscience.org/library/papers/42125750PubMed
42122155Targeting Autophagy to Overcome Chemoresistance and Immune Resistance in Triple-Negative Breast Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42122155PubMed
42121934Research on the Hippo Pathway in Cancer.Cells2026https://conductscience.org/library/papers/42121934PubMed
41938591The Roles of Protein S-Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential.Cancer Commun (Lond)2026https://conductscience.org/library/papers/41938591PubMed
41881106Reduced podocyte stiffness is a feature of proteinuric kidney disease.Kidney Int2026https://conductscience.org/library/papers/41881106PubMed

See all 152 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
NF24771PubTator's text mininghttps://conductscience.org/library/genes/4771NCBI Gene
TAFAZZIN6901PubTator's text mininghttps://conductscience.org/library/genes/6901NCBI Gene
YAP110413PubTator's text mininghttps://conductscience.org/library/genes/10413NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33850002

GET https://conductscience.org/api/papers/v1/33850002/cited_by?page=2